Topic: spinal cord injury
The past week’s biotech news included a method for regrowing nerves by turning off genes and a potential combo to treat resistant lung cancer.
A new trial published in Nature has seen a combination of spinal cord therapy (SCS) and physical therapy help patients walk again.
The lack of efficacy seen in the phase 2b is another, potentially terminal, blow to the prospects of the Rho inhibitor.
Joint replacement and spinal surgery company Medacta International is gaining a new chief executive.
Two of four paralyzed patients who underwent an experimental electrode treatment and physical therapy regained the ability to walk with limited help.
Blocking a pathway that causes healing cells to turn bad could offer a new way to treat neurological disorders.
Researchers from King's College London designed a gene therapy that can be switched off once it has treated a spinal cord injury.
Switching on the LZK gene in mice with spinal cord injuries led to a smaller scar, which might improve healing.
Scientists have discovered key stem cells that help the gecko tail regenerate—insights that may spur therapies for people with spinal cord injuries.
ReWalk Robotics is gearing up for the clinical testing of its soft suit exoskeleton, which it plans to launch next year.